Organon (OGN) Research & Development (2020 - 2026)
Organon (OGN) reported Research & Development of $83 million for Q3 2026, down 1.2% from $84 million a year earlier and down 7.8% from the prior quarter.
Powered by 
Analysis
Organon (OGN) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Organon's Research & Development came in at $357 million, down 11.9% year-over-year; for FY2025, it was $366 million, down 22.0% from FY2024.
- Research & Development has a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- By year, Research & Development came in at $469 million in FY2024 (-11.2%), $528 million in FY2023 (+12.1%), $471 million in FY2022 (+38.9%) and $339 million in FY2021 (+61.4%).
- The Q3 2026 figure ranks as the lowest quarterly Research & Development since Q2 2021.
- Year over year, Research & Development has now declined in each of the last 12 quarters, with an average decline of 12.4% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q4 2021 (growth of 83.3%); the low point was Q4 2025 (a decline of 30.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $90 million (Q2 2026), $93 million (Q1 2026) and $91 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Organon | 3.65 Bn | -629.18 Mn | 869.00 Mn | 83.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 83.00 Mn |
| Jun 30, 2026 | 90.00 Mn |
| Mar 31, 2026 | 93.00 Mn |
| Dec 31, 2025 | 91.00 Mn |
| Sep 30, 2025 | 84.00 Mn |
| Jun 30, 2025 | 95.00 Mn |
| Mar 31, 2025 | 96.00 Mn |
| Dec 31, 2024 | 130.00 Mn |
| Sep 30, 2024 | 111.00 Mn |
| Jun 30, 2024 | 116.00 Mn |
| Mar 31, 2024 | 112.00 Mn |
| Dec 31, 2023 | 134.00 Mn |
| Sep 30, 2023 | 137.00 Mn |
| Jun 30, 2023 | 128.00 Mn |
| Mar 31, 2023 | 129.00 Mn |
| Dec 31, 2022 | 142.00 Mn |
| Sep 30, 2022 | 127.00 Mn |
| Jun 30, 2022 | 106.00 Mn |
| Mar 31, 2022 | 96.00 Mn |
| Dec 31, 2021 | 110.00 Mn |
API Access
Organon Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();